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Data regarding the cause of death in different countries reve-
aled that while cancers were the main causes of death in devel-
oped countries, infections and parasitic diseases were considered
as the main causes of death in underdeveloped countries. In the
year 2002, the mean estimated death due to infectious and par-
asitic diseases per 100,000 population in 15 developed and
developing countries was 12.6 and 962.6, respectively, whereas
due to cancers it was 230.6 for developed and 59.8 for develop-
ing countries in the same year [1]. The difference in the cause of
death in those countries was statistically significant. Moreover,
in the United States, public health interventions for control of
infectious diseases have been associated with a parallel increase
in mortality rates for cancers [2]. Various factors such as air pol-
lution and dietary habits may be responsible for the increase in
the cancer mortality following control of infectious and parasitic
diseases. However, there are raising scientific evidences indicat-
ing that parasitic or bacterial infections induce antitumor activ-
ity against certain types of cancers [3-8]. For example, anticancer
activity of Trypanozoma cruzi parasites has been demonstrated
[3], and it has been shown that Bacillus Calmette Guerin (BCG)
is an effective immunotherapy for carcinoma of the bladder, as
reviewed by Herr et al. [8]. The present study aimed to examine
the above hypothesis on the effects of Toxoplasma gondii and
Toxocara canis egg antigens in comparison with BCG, which is
known to have antitumor characteristics, on fibosarcoma devel-
opment in BALB/c mice.
For 2 separate experiments, 8-wk-old male inbred BALB/c
mice (5-6 mice in each group) were used. In the first experiment,
each mouse (group 1) was injected with 120 mg T. gondii anti-
gen in 100 μl isotonic saline absorbed on 100 μl alum adjuvant.
In the case of group 2 (positive control), every mouse was inject-
ed in food pad with 20 μl BCG and in the negative control group
every mouse was injected with 100 μl saline absorbed on 100 μl
alum as the adjuvant. In the second experiment, each mouse was
injected with 120 mg T. canis egg antigen in 100 μl isotonic saline
absorbed on 100 μl alum as the adjuvant. The control group was
injected as the negative control group of the first experiment. All
mice were received 2 boosters fortnightly with the same anti-
gens in case groups or alum alone in control groups.
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Abstract: Cancer is the main cause of death in developed countries. However, in underdeveloped countries infections and
parasitic diseases are the main causes of death. There are raising scientific evidences indicating that parasitic infections
induce antitumor activity against certain types of cancers. In this study, the effects of Toxoplasma gondii and Toxocara
canis egg antigens in comparison with Bacillus Calmette Guerin (BCG) (known to have anticancer distinctive) on WEHI-
164 fibosarcoma transplanted to BALB/c mice was investigated. Groups of 6 male BALB/c mice injected with T. gondii
antigen, BCG, or T. canis egg antigen as case groups and alum alone as control groups. All mice were then challenged
with WEHI-164 fibrosarcoma cells. The mice were examined for growth of the solid tumor and the tumor sizes were mea-
sured every other day up to 4 wk. The mean tumor area in T. gondii, BCG, or alum alone injected mice in 4 different days
of measurements was 25 mm2, 23 mm2, and 186 mm2 respectively. Also the mean tumor area in T. canis injected mice in
4 different days was 25.5 mm2 compared to the control group (alum treated) which was 155 mm2. T. gondii parasites and
T. canis egg antigens induced inhibition of the tumor growth in the fibrosarcoma mouse model. We need further study to
clarify the mechanisms of anti-cancer effects.
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Two weeks after the last booster all mice in case and control
groups were challenged with 5 × 105 WEHI-164 fibrosarcoma
cells suspended in 200 μl culture medium. The cells were inject-
ed subcutaneously in the chest place of the animals. Three days
after the tumor cell inoculation mice were examined for detec-
tion of solid tumors in the injected locations. When the tumor
was detectable in the examination, its size was measured in 2
diameters every 2 days up to 1 month. It was supposed that the
tumors have sphere shape and so the tumor area was calculat-
ed according to the following formula which is the modifica-
tion of the sphere area formula. This formula was first used for
the tumor area calculation in a PhD thesis at University of New-
castle, Australia, by Shirzadeh, H. 1n 1995.
π× (Diameter 1 + Diameter 2)
2
Tumor area =
4
Toxoplasma antigen was prepared by centrifugation of RH
tachyzoites to make a concentration containing 6 × 105 para-
sites per ml. The suspension was frozen and thawed 5 times with
the presence of Fenil metil solfonil floraid. The antigen was then
stored at -20. The BCG vaccine is a live attenuated lyophilized
bovine mycobacterium containing 1.5-6.0 × 106 bacteria per
ml. This vaccine was purchased from Pasture institute, Tehran,
Iran. WEHI -164 cells are fibrosarcoma cells of BALB/c inbred
mice purchased from the cell bank of Pasture Institute, Tehran,
Iran.
T. canis egg antigen was prepared by harvesting the eggs from
the uterus of female worms. These eggs were kept in isotonic
saline for 2 wk and then sonicated. The sonicated mixture was
kept at -20℃ for use as the antigen. Kruskal Wallis and Mann-
Whitney tests were used for statistical analysis.
In the first experiment, the solid tumors were detectable 17
days after the cell injection. The tumor sizes were measured on
days 17th, 21th, 26th, and 31th after the cell inoculation. The
mean area of tumors in T. gondii, BCG, or alum alone injected
mice in 4 different days of measurements were 25 mm2, 23 mm2,
and 186 mm2, respectively (Table 1).
In the second experiment the solid tumors were detectable
15 days following the cell challenge. The tumor size was mea-
sured on days 15th, 17th, 22th, and 26th and the mean tumor
area in T. canis injected mice in 4 different days was 24.5 mm2
compared to the control group (alum treated) which was 155
mm2 (Table 2). 
The results of this study demonstrated that injection of 2 par-
asite antigens, T. gondii and T. canis, associated with a significant
reduction in the tumor size in comparison with the control group
(no antigen injected). There are scientific evidences indicating
that some parasitic and microbial infections interfere with tumor
growth and have anticancer activities [3-8]. Plumelle et al. [6]
showed that patients with leukemia who were infected with
Strongyloides stercoralis parasites survived longer compared with
the same patients without S. stercoralis infection. In another inves-
tigation, tumoricidal potential of a pathogenic ameba in cell
cultures has been demonstrated [7]. It has been shown that T.
cruzi infection confers resistance to the tumor development in
mice, and also in vitro studies have shown toxic effects of para-
site extracts on the cancer in cell cultures [3,4]. T. gondii infection
inhibits the tumor growth in certain types of cancers in mouse
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Groups
Day after cell injection
Day 17th Day 21th Day 26th Day 31th
Case 1
Mean 3.18 22.68 35.36 41.02
SD 7.11 45.54 47.05 54.60
Case 2
Mean 0.00 5.66 40.22 47.62
SD 0.00 12.65 57.23 67.38
Control
Mean 42.48 117.40 267.10 319.18
SD 82.33 96.32 168.32 206.10
P Not Not 0.023 0.032
significant significant
Table 1. The tumor area (mean and SD; mm2) of mice injected
with Toxoplasma gondii antigen absorbed on alum (case 1), BCG
(case 2) and alum alone (control) following 17, 21, 26, and 31 days
after challenge with fibrosarcoma cells
Data are from 5 mice in each group.
BCG, Bacillus Calmette Guerin.
Groups
Day after cell injection
Day 15th Day 17th Day 22th Day 26th
Case
Mean 4.41 21.33 35.58 36.50
SD 6.86 45.21 55.15 54.63
Control
Mean 49.98 93.33 222.58 255.03
SD 108.75 87.09 101.55 117.37
P Not Not 0.004 0.004
significant significant
Table 2. The tumor area (mean and SD; mm2) of mice injected
with Toxocara canis egg antigen absorbed on alum (case group)
in comparison with mice injected with alum alone (control group)
following 15, 17, 21, and 26 days after challenge with fibrosarco-
ma cells 
Data are from 6 mice in each group.
models through induction of Th1 immure responses and anti-
angiogenic activities [5]. However, there are also some evidences
indicating that parasitic infections enhance cancer growth or pre-
dispose patients to malignancies [9-13].
How parasite antigens interfere with the tumor growth and
what is the mechanism of anticancer effects of those antigens
are not understood. One possibility is that immune responses
provoked by parasite antigens may be non-specifically effective
toward tumor cells. In this context, it has been shown that immu-
nization of mice against T. cruzi provided co-protective effects
against the transplanted tumor [14]. In another study, Kim et
al. [5] demonstrated that T. gondii infection inhibits the tumor
growth in the Lewis lung carcinoma mouse model through in-
duction of Th1 immune responses and antiangiogenic activities.
Moreover, natural killer (NK) cells which are activated in some
parasitic and microbial infections [15-18] may nonspecifically
affect the tumor cells [17,18]. In 2007, the involvement of NK
cells against tumors and parasites has been reviewed by Papa-
zahariadou et al. [17]. However, further work is necessary to find
out the exact mechanisms involved in antitumor activities of
those 2 parasite antigens.
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